We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

4684:TSEOBIC Co., Ltd. Analysis

Data as of 2026-07-03 - not real-time

¥4,001.00

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

OBIC Co.,Ltd. is trading below its short‑term moving average while still above a key support level, creating a mixed momentum picture. The relative strength index sits in a neutral zone, suggesting the stock is neither overbought nor oversold, and the MACD histogram is positive, offering a bullish tilt despite an overall bearish trend. Volatility is elevated, yet beta is near zero, indicating that price swings are largely company‑specific rather than market‑driven. Fundamentally, the company boasts strong operating and profit margins, a solid cash position, zero net debt, and a dividend yield that comfortably exceeds two percent, underscoring financial resilience. A discounted cash flow model places fair value above the current price, implying upside potential, while the industry’s price‑to‑earnings multiple is higher than the stock’s, highlighting a relative valuation advantage. The fear‑and‑greed index reflects extreme greed in the market, which may be inflating sentiment.
Overall, the combination of robust fundamentals, attractive dividend sustainability, and undervalued pricing relative to peers supports a positive outlook, though the high volatility and bearish technical bias warrant cautious positioning.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • price near short‑term support
  • mixed moving‑average alignment
  • high volatility with low market correlation

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • DCF‑derived upside
  • strong cash generation and zero debt
  • attractive dividend yield

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • consistent revenue growth and high margins
  • stable dividend policy
  • relative valuation advantage versus industry peers

Key Metrics & Analysis

Financial Health

Revenue Growth11.40%
Profit Margin55.61%
P/E Ratio23.3
ROE15.83%
ROA9.92%
P/B Ratio3.4
Op. Cash Flow¥73.7B
Free Cash Flow¥59.0B
Industry P/E36.0

Technical Analysis

TrendBearish
RSI56.7
Support¥3,643.00
Resistance¥4,057.00
MA 20¥3,835.55
MA 50¥4,020.46
MA 200¥4,475.68
MACDBullish
VolumeStable
Fear & Greed Index92.59

Valuation

Fair Value¥3,396.95
Target Price¥5,120.00
Upside/Downside27.97%
GradeUndervalued
TypeBlend
Dividend Yield2.39%

Risk Assessment

Beta-0.09
Volatility33.37%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.